|Articles|September 17, 2019

Almac Group Participates in GCSBWG

Almac Group is pleased to announce its participation in the Global Clinical Supply BlockChain working group.Almac joins other GCSBWGmembers like those from Pfizer, Merck, UCLA, Bracket, Thermo Fisher, and many more.

For details, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

© putilov_denis - © putilov_denis - stock.adobe.com

From Participation to Understanding: Reframing Engagement in Clinical Trials

September 9th 2026

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

ByOtis Johnson, PhD, MPA,Joseph Geraci, PhD,Andy Studna, Senior Editor

September 9th 2026

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis

ByAndy Studna, Senior Editor

September 9th 2026

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run

ByPatrick Mizer,Andy Studna, Senior Editor

September 8th 2026

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ByAbigail Dirks, MS,Sylviane de Viron,Andy Studna, Senior Editor

September 8th 2026

Trending on Applied Clinical Trials Online

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run

From Participation to Understanding: Reframing Engagement in Clinical Trials

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable